HECHT BETH (See Remarks) reported 1 transaction at XERIS BIOPHARMA HOLDINGS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/7/2025ACC: 0001867096-25-000011
Officer· See Remarks
Since Oct 2021
-32.04K
Net shares
Net seller
$115.7K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
32.04K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−32.04K
Price / share
$3.61
Trade value
$115.66K
% of position
2.3%
1/3/2025
1.38M→1.35M
Total
Net shares
−32.04K
Net value
-$115.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2025 | F · Tax Withholding | −32.04K | $3.61 | $115.66K | 2.3% | 1.38M | 1.35M |
| Total | −32.04K | -$115.66K | ||||||
Derivative Transactions0
No derivative transactions reported